STOCK TITAN

Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2025 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Oaktree Specialty Lending Corporation (NASDAQ: OCSL) reported its Q2 2025 financial results, showing significant declines across key metrics. Total investment income decreased to $77.6M ($0.90 per share) from $86.6M ($1.05 per share) in Q1 2025, primarily due to a smaller investment portfolio and non-accrual investments. Net asset value (NAV) per share fell to $16.75 from $17.63 in the previous quarter. The company originated $407.0M in new investment commitments with a 9.5% weighted average yield on new debt investments. Notable transactions included a $100M share purchase by Oaktree Capital I at NAV and issuance of $300M in unsecured notes. The Board declared a quarterly distribution of $0.40 per share plus a $0.02 supplemental distribution, payable June 30, 2025. Non-accrual investments increased to 4.6% of debt investments at fair value, up from 3.9% in the previous quarter.
Oaktree Specialty Lending Corporation (NASDAQ: OCSL) ha comunicato i risultati finanziari del secondo trimestre 2025, evidenziando cali significativi nei principali indicatori. Il reddito totale da investimenti è sceso a 77,6 milioni di dollari (0,90 dollari per azione) rispetto a 86,6 milioni di dollari (1,05 dollari per azione) nel primo trimestre 2025, principalmente a causa di un portafoglio investimenti ridotto e investimenti non redditizi. Il valore patrimoniale netto (NAV) per azione è diminuito a 16,75 dollari da 17,63 dollari nel trimestre precedente. La società ha originato nuovi impegni di investimento per 407,0 milioni di dollari con un rendimento medio ponderato del 9,5% sui nuovi investimenti in debito. Tra le operazioni rilevanti, si segnala un acquisto di azioni per 100 milioni di dollari da parte di Oaktree Capital I al NAV e l'emissione di 300 milioni di dollari in note non garantite. Il Consiglio ha dichiarato una distribuzione trimestrale di 0,40 dollari per azione più una distribuzione supplementare di 0,02 dollari, pagabile il 30 giugno 2025. Gli investimenti non redditizi sono aumentati al 4,6% degli investimenti in debito a valore equo, rispetto al 3,9% del trimestre precedente.
Oaktree Specialty Lending Corporation (NASDAQ: OCSL) reportó sus resultados financieros del segundo trimestre de 2025, mostrando descensos significativos en métricas clave. Los ingresos totales por inversiones disminuyeron a 77,6 millones de dólares (0,90 dólares por acción) desde 86,6 millones de dólares (1,05 dólares por acción) en el primer trimestre de 2025, principalmente debido a una cartera de inversiones más pequeña y a inversiones en mora. El valor neto de los activos (NAV) por acción cayó a 16,75 dólares desde 17,63 dólares en el trimestre anterior. La compañía originó compromisos de inversión nuevos por 407,0 millones de dólares con un rendimiento promedio ponderado del 9,5% en nuevas inversiones de deuda. Entre las transacciones destacadas se incluyó una compra de acciones por 100 millones de dólares por parte de Oaktree Capital I al NAV y la emisión de 300 millones de dólares en notas no garantizadas. La Junta declaró una distribución trimestral de 0,40 dólares por acción más una distribución suplementaria de 0,02 dólares, pagadera el 30 de junio de 2025. Las inversiones en mora aumentaron al 4,6% de las inversiones en deuda a valor razonable, frente al 3,9% del trimestre anterior.
Oaktree Specialty Lending Corporation (NASDAQ: OCSL)는 2025년 2분기 재무 실적을 발표했으며 주요 지표에서 상당한 감소를 보였습니다. 총 투자 수익은 7,760만 달러 (주당 0.90달러)로 2025년 1분기의 8,660만 달러(주당 1.05달러)에서 감소했으며, 이는 주로 투자 포트폴리오 축소와 미수익 투자 때문입니다. 주당 순자산가치(NAV)는 16.75달러로 전 분기의 17.63달러에서 하락했습니다. 회사는 4억 700만 달러의 신규 투자 약정을 체결했으며 신규 부채 투자에 대해 9.5%의 가중 평균 수익률을 기록했습니다. 주요 거래로는 Oaktree Capital I이 NAV 기준으로 1억 달러의 주식 매입과 3억 달러의 무담보 채권 발행이 포함되었습니다. 이사회는 주당 0.40달러의 분기 배당금과 0.02달러의 추가 배당금을 선언했으며, 지급일은 2025년 6월 30일입니다. 미수익 투자는 공정 가치 기준 부채 투자에서 3.9%에서 4.6%로 증가했습니다.
Oaktree Specialty Lending Corporation (NASDAQ : OCSL) a publié ses résultats financiers du deuxième trimestre 2025, montrant des baisses significatives sur les indicateurs clés. Le revenu total des investissements a diminué à 77,6 millions de dollars (0,90 dollar par action) contre 86,6 millions de dollars (1,05 dollar par action) au premier trimestre 2025, principalement en raison d’un portefeuille d’investissements plus réduit et d’investissements non productifs. La valeur nette d’actif (VNA) par action est tombée à 16,75 dollars contre 17,63 dollars au trimestre précédent. La société a généré 407,0 millions de dollars d’engagements d’investissement nouveaux avec un rendement moyen pondéré de 9,5 % sur les nouveaux investissements en dette. Parmi les opérations notables figurent un achat d’actions de 100 millions de dollars par Oaktree Capital I au prix de la VNA et l’émission de 300 millions de dollars en billets non garantis. Le Conseil a déclaré une distribution trimestrielle de 0,40 dollar par action plus une distribution supplémentaire de 0,02 dollar, payable le 30 juin 2025. Les investissements non productifs ont augmenté pour représenter 4,6 % des investissements en dette à la juste valeur, contre 3,9 % au trimestre précédent.
Die Oaktree Specialty Lending Corporation (NASDAQ: OCSL) veröffentlichte ihre Finanzergebnisse für das zweite Quartal 2025 und verzeichnete dabei deutliche Rückgänge bei wichtigen Kennzahlen. Das gesamte Investmentergebnis sank auf 77,6 Mio. USD (0,90 USD je Aktie) von 86,6 Mio. USD (1,05 USD je Aktie) im ersten Quartal 2025, hauptsächlich aufgrund eines kleineren Investmentportfolios und notleidender Investitionen. Der Nettoinventarwert (NAV) je Aktie fiel auf 16,75 USD von 17,63 USD im Vorquartal. Das Unternehmen tätigte neue Investitionszusagen in Höhe von 407,0 Mio. USD mit einer gewichteten durchschnittlichen Rendite von 9,5 % auf neue Schuldeninvestitionen. Zu den bemerkenswerten Transaktionen gehörten ein Aktienkauf von 100 Mio. USD durch Oaktree Capital I zum NAV und die Ausgabe von 300 Mio. USD unbesicherter Schuldverschreibungen. Der Vorstand erklärte eine vierteljährliche Ausschüttung von 0,40 USD je Aktie plus einer zusätzlichen Ausschüttung von 0,02 USD, zahlbar am 30. Juni 2025. Die notleidenden Investitionen stiegen auf 4,6 % der Schuldeninvestitionen zum beizulegenden Zeitwert, gegenüber 3,9 % im Vorquartal.
Positive
  • Originated $407.0M in new investment commitments with 9.5% weighted average yield on new debt investments
  • Maintained stable quarterly distribution of $0.40 per share plus $0.02 supplemental distribution
  • Strong liquidity position with $97.8M cash and over $1.0B undrawn credit capacity
  • $100M share purchase by Oaktree Capital I at NAV, representing 10% premium to market price
Negative
  • Total investment income declined to $77.6M from $86.6M quarter-over-quarter
  • NAV per share decreased to $16.75 from $17.63 due to losses on investments
  • Non-accrual investments increased to 4.6% of debt investments from 3.9% quarter-over-quarter
  • Net realized and unrealized losses of $75.3M, significantly higher than previous quarter's $37.1M loss

Insights

OCSL shows deteriorating portfolio quality with rising non-accruals and NAV decline, though maintains dividend coverage and strong liquidity position.

Oaktree Specialty Lending's Q2 2025 results reveal significant credit quality deterioration and performance challenges. Total investment income declined 10.4% sequentially to $77.6 million, with net investment income per share falling 16.7% to $0.45. The most concerning metric is the substantial increase in non-accrual investments, which rose to 7.6% of the portfolio at cost (up from 5.1% last quarter) and 4.6% at fair value (up from 3.9%). The number of non-accrual investments increased to 10 from 9 last quarter and 5 a year ago.

These credit issues directly contributed to substantial net realized and unrealized losses of $75.3 million, driving NAV per share down 5.0% from $17.63 to $16.75. The portfolio's weighted average yield compressed to 10.2% from 10.7% last quarter and 12.2% a year ago, reflecting both falling reference rates and credit challenges.

Despite these headwinds, OCSL has maintained its total distribution of $0.42 per share ($0.40 base + $0.02 supplemental), which remains covered by the $0.45 NII per share. The company strengthened its capital structure by receiving a $100 million equity injection from Oaktree Capital at NAV in February, and successfully refinanced its 2025 notes with new $300 million notes due 2030. The company has prudently reduced leverage with a debt-to-equity ratio of 1.00x, down from 1.11x, while maintaining strong liquidity with $97.8 million in cash and over $1 billion in undrawn capacity.

OCSL faces portfolio stress with rising non-accruals and NAV erosion, balanced by sponsor support and maintained distribution coverage.

The Q2 results reveal concerning portfolio deterioration that requires close investor attention. The 5.0% NAV decline in a single quarter (from $17.63 to $16.75) is particularly noteworthy, driven by $75.3 million in net realized and unrealized losses. Credit quality metrics have markedly worsened, with non-accruals increasing to 4.6% of the portfolio at fair value, up from 3.9% last quarter and 2.4% a year ago. The doubling of non-accrual investments from 5 to 10 year-over-year suggests this represents broader portfolio stress rather than isolated issues.

Management's explicit acknowledgment that "certain challenged portfolio company investments weighed on our results" confirms these difficulties, though they expressed a focus on "resolving these issues while also positioning our portfolio to deliver more consistent performance."

On the positive side, OCSL maintains several key strengths. The current distribution ($0.40 base + $0.02 supplemental) remains covered by the $0.45 NII per share. Oaktree Capital demonstrated significant sponsor support through a $100 million equity investment at NAV, representing a 10% premium to market price.

OCSL's investment activity shows continued market access, with $407 million in new commitments across 24 new portfolio companies. The weighted average yield on new debt investments was 9.5%, below the existing portfolio yield of 10.2%, suggesting disciplined underwriting despite market challenges. With over $1 billion in undrawn capacity, the company maintains substantial dry powder, positioning it to potentially capitalize on market dislocations as management noted.

LOS ANGELES, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter ended March 31, 2025.

Financial Highlights for the Quarter Ended March 31, 2025

  • Total investment income was $77.6 million ($0.90 per share) for the second fiscal quarter of 2025, as compared with $86.6 million ($1.05 per share) for the first fiscal quarter of 2025. Adjusted total investment income was $77.2 million ($0.90 per share) for the second fiscal quarter of 2025, as compared with $87.1 million ($1.06 per share) for the first fiscal quarter of 2025. The decrease was driven by lower interest income, which was primarily attributable to a smaller average investment portfolio, the impact of certain investments that were placed on non-accrual status and decreases in reference rates.
  • GAAP net investment income was $39.1 million ($0.45 per share) for the second fiscal quarter of 2025, as compared with $44.3 million ($0.54 per share) for the first fiscal quarter of 2025. The decrease for the quarter was primarily driven by lower total investment income, partially offset by lower interest expense and income-based (“Part I”) incentive fees (net of fees waived).
  • Adjusted net investment income was $38.7 million ($0.45 per share) for the second fiscal quarter of 2025, as compared with $44.7 million ($0.54 per share) for the first fiscal quarter of 2025. The decrease for the quarter was primarily driven by lower adjusted total investment income, partially offset by lower interest expense and lower Part I incentive fees (net of fees waived).
  • Net asset value (“NAV”) per share was $16.75 as of March 31, 2025, down as compared with $17.63 as of December 31, 2024. The decline from December 31, 2024 primarily reflected losses on certain debt and equity investments.
  • Originated $407.0 million of new investment commitments and received $279.4 million of proceeds from prepayments, exits, other paydowns and sales during the quarter ended March 31, 2025. The weighted average yield on new debt investments was 9.5%.
  • Total debt outstanding was $1,470.0 million as of March 31, 2025. The total debt to equity ratio was 1.00x, and the net debt to equity ratio was 0.93x, after adjusting for cash and cash equivalents.
  • Oaktree Capital I, L.P. purchased $100.0 million of shares of OCSL common stock on February 3, 2025 at the Company’s net asset value as of January 31, 2025, which was $17.63 per share and represented a 10% premium to the closing stock price.
  • The Company issued $300 million of unsecured notes during the quarter ended March 31, 2025 that mature on February 27, 2030 and bear interest at a rate of 6.340%. In connection with the issuance of the 2030 Notes, the Company entered into an interest rate swap agreement under which the Company receives a fixed interest rate of 6.340% and pays a floating interest rate of the three-month SOFR plus 2.192% on a notional amount of $300.0 million. Additionally, the Company repaid $300 million of unsecured notes that matured on February 25, 2025.
  • Liquidity as of March 31, 2025 was composed of $97.8 million of unrestricted cash and cash equivalents and over $1.0 billion of undrawn capacity under the Company's credit facilities (subject to borrowing base and other limitations). Unfunded investment commitments were $299.8 million, or $272.6 million excluding unfunded commitments to the Company's joint ventures. Of the $272.6 million, approximately $252.0 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions.
  • A quarterly and supplemental cash distribution was declared of $0.40 per share and $0.02 per share, respectively, payable in cash on June 30, 2025 to stockholders of record on June 16, 2025.

“Certain challenged portfolio company investments weighed on our results in the second quarter. We are focused on resolving these issues while also positioning our portfolio to deliver more consistent performance going forward,” stated Armen Panossian, Chief Executive Officer and Co-Chief Investment Officer.

“We are focused on further diversifying our portfolio by selectively investing in companies we believe are well positioned to deliver attractive returns given overall market uncertainty caused by tariffs, inflation and high interest rates. Historically, in periods of market volatility, our firm-wide DNA has enabled us to capitalize on opportunities while others are sidelined, and we have ample dry powder for new investments.”

Distribution Declaration

The Board of Directors declared a quarterly distribution of $0.40 per share, payable in cash on June 30, 2025 to stockholders of record on June 16, 2025. The Board of Directors also declared a supplemental distribution of $0.02 per share, payable in cash on June 30, 2025 to stockholders of record on June 16, 2025.

Distributions are paid primarily from distributable (taxable) income. To the extent taxable earnings for a fiscal taxable year fall below the total amount of distributions for that fiscal year, a portion of those distributions may be deemed a return of capital to the Company’s stockholders.

Results of Operations

 For the three months ended
 
($ in thousands, except per share data)March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
GAAP operating results:            
Interest income$70,523  $78,422  $85,256  
PIK interest income 4,531   5,728   4,816  
Fee income 1,742   1,679   2,546  
Dividend income 772   818   1,411  
Total investment income 77,568   86,647   94,029  
Net expenses 38,235   42,082   52,662  
Net investment income before taxes 39,333   44,565   41,367  
(Provision) benefit for taxes on net investment income (278)  (263)    
Net investment income 39,055   44,302   41,367  
Net realized and unrealized gains (losses), net of taxes (75,304)  (37,063)  (32,030) 
Net increase (decrease) in net assets resulting from operations$(36,249) $7,239  $9,337  
Total investment income per common share$0.90  $1.05  $1.18  
Net investment income per common share$0.45  $0.54  $0.52  
Net realized and unrealized gains (losses), net of taxes per common share$(0.88) $(0.45) $(0.40) 
Earnings (loss) per common share — basic and diluted$(0.42) $0.09  $0.12  
Non-GAAP Financial Measures1:            
Adjusted total investment income$77,195  $87,070  $97,340  
Adjusted net investment income$38,682  $44,725  $44,678  
Adjusted net realized and unrealized gains (losses), net of taxes$(75,248) $(37,124) $(35,344) 
Adjusted earnings (loss)$(36,566) $7,601  $9,334  
Adjusted total investment income per share$0.90  $1.06  $1.22  
Adjusted net investment income per share$0.45  $0.54  $0.56  
Adjusted net realized and unrealized gains (losses), net of taxes per share$(0.88) $(0.45) $(0.44) 
Adjusted earnings (loss) per share$(0.43) $0.09  $0.12  
             
1 See Non-GAAP Financial Measures below for a description of the non-GAAP measures and the reconciliations from the most comparable GAAP financial measures to the Company's non-GAAP measures, including on a per share basis. The Company's management uses these non-GAAP financial measures internally to analyze and evaluate financial results and performance and believes that these non-GAAP financial measures are useful to investors as an additional tool to evaluate ongoing results and trends for the Company and to review the Company’s performance without giving effect to non-cash income/gain/loss resulting from the merger of Oaktree Strategic Income Corporation (“OCSI”) with and into the Company in March 2021 (the “OCSI Merger”) and the merger of Oaktree Strategic Income II, Inc. (“OSI2”) with and into the Company in January 2023 (the “OSI2 Merger”) and, in the case of adjusted net investment income, without giving effect to capital gains incentive fees. The presentation of non-GAAP measures is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
 


 As of
 
($ in thousands, except per share data and ratios)March 31, 2025
(unaudited)

 December 31, 2024
(unaudited)

 March 31, 2024
(unaudited)

 
Select balance sheet and other data:            
Cash and cash equivalents$97,838  $112,913  $125,031  
Investment portfolio at fair value 2,892,771   2,835,294   3,047,445  
Total debt outstanding (net of unamortized financing costs) 1,448,486   1,577,795   1,635,642  
Net assets 1,475,113   1,449,815   1,524,099  
Total debt to equity ratio 1.00x  1.11x  1.10x 
Net debt to equity ratio 0.93x  1.03x  1.02x 
 

Adjusted total investment income for the quarter ended March 31, 2025 was $77.2 million and included $70.2 million of interest income from portfolio investments, $4.5 million of payment-in-kind (“PIK”) interest income, $1.7 million of fee income and $0.8 million of dividend income. The $9.9 million quarterly decline in adjusted total investment income was primarily due to a $9.9 million decrease in interest income, which was primarily attributable to a smaller average investment portfolio, the impact of certain investments that were placed on non-accrual status and decreases in reference rates.

Net expenses for the quarter ended March 31, 2025 totaled $38.2 million, down $3.8 million from the quarter ended December 31, 2024. The decrease for the quarter was primarily driven by $2.4 million of lower interest expense due to lower outstanding borrowings and lower reference rates on the Company's floating rate debt and $1.5 million of lower Part I incentive fees (net of fees waived).

Adjusted net investment income was $38.7 million ($0.45 per share) for the quarter ended March 31, 2025, which was down from $44.7 million ($0.54 per share) for the quarter ended December 31, 2024. The decline of $6.0 million primarily reflected $9.9 million of lower adjusted total investment income, offset by $3.9 million of lower net expenses.

Adjusted net realized and unrealized losses, net of taxes, were $75.2 million for the quarter ended March 31, 2025.

Portfolio and Investment Activity

 As of
 
($ in thousands)March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
Investments at fair value$2,892,771  $2,835,294  $3,047,445  
Number of portfolio companies 152   136   151  
Average portfolio company debt size$19,700  $22,000  $20,100  
             
Asset class:            
First lien debt 80.9%  81.8%  80.8% 
Second lien debt 3.4%  3.0%  5.4% 
Unsecured debt 5.0%  3.9%  2.6% 
Equity 4.6%  4.8%  4.8% 
JV interests 6.1%  6.5%  6.4% 
             
Non-accrual debt investments:            
Non-accrual investments at fair value$125,643  $105,326  $69,128  
Non-accrual investments at cost 217,401   138,703   127,720  
Non-accrual investments as a percentage of debt investments at fair value 4.6%  3.9%  2.4% 
Non-accrual investments as a percentage of debt investments at cost 7.6%  5.1%  4.3% 
Number of investments on non-accrual 10   9   5  
             
Interest rate type:            
Percentage floating-rate 89.8%  87.6%  85.4% 
Percentage fixed-rate 10.2%  12.4%  14.6% 
             
Yields:            
Weighted average yield on debt investments1 10.2%  10.7%  12.2% 
Cash component of weighted average yield on debt investments 9.3%  9.5%  11.0% 
Weighted average yield on total portfolio investments2 9.8%  10.2%  11.7% 
             
Investment activity:            
New investment commitments$407,000  $198,100  $395,600  
New funded investment activity3$405,800  $201,300  $377,400  
Proceeds from prepayments, exits, other paydowns and sales$279,400  $352,400  $322,600  
Net new investments4$126,400  $(151,100) $54,800  
Number of new investment commitments in new portfolio companies 24   5   20  
Number of new investment commitments in existing portfolio companies 8   8   15  
Number of portfolio company exits 8   13   15  
             
1 Annual stated yield earned plus net annual amortization of OID or premium earned on accruing investments, including the Company's share of the return on debt investments in SLF JV I and Glick JV, and excluding any amortization or accretion of interest income resulting solely from the cost basis established by ASC 805 (see Non-GAAP Financial Measures below) for the assets acquired in connection with the OCSI Merger and OSI2 Merger.
2 Annual stated yield earned plus net annual amortization of OID or premium earned on accruing investments and dividend income, including the Company's share of the return on debt investments in SLF JV I and Glick JV, and excluding any amortization or accretion of interest income resulting solely from the cost basis established by ASC 805 for the assets acquired in connection with the OCSI Merger and OSI2 Merger.
3 New funded investment activity includes drawdowns on existing revolver and delayed draw term loan commitments.
4 Net new investments consists of new funded investment activity less proceeds from prepayments, exits, other paydowns and sales.
 

As of March 31, 2025, the fair value of the investment portfolio was $2.9 billion and was composed of investments in 152 companies. These included debt investments in 131 companies, equity investments in 40 companies, and the Company's joint venture investments in SLF JV I and OCSI Glick JV LLC (“Glick JV”). 21 of the equity investments were in companies in which the Company also had a debt investment.

As of March 31, 2025, 94.9% of the Company's portfolio at fair value consisted of debt investments, including 80.9% of first lien loans, 3.4% of second lien loans and 10.6% of unsecured debt investments, including the debt investments in SLF JV I and Glick JV. This compared to 81.8% of first lien loans, 3.0% of second lien loans and 9.6% of unsecured debt investments, including the debt investments in SLF JV I and Glick JV, as of December 31, 2024.

As of March 31, 2025, there were ten investments on non-accrual status, which represented 7.6% and 4.6% of the debt portfolio at cost and fair value, respectively. As of December 31, 2024, there were nine investments on non-accrual status, which represented 5.1% and 3.9% of the debt portfolio at cost and fair value, respectively.

SLF JV I

The Company's investments in SLF JV I totaled $128.6 million at fair value as of March 31, 2025, down 5.0% from $135.4 million as of December 31, 2024. The decrease was primarily driven by SLF JV I’s use of leverage and unrealized depreciation in the underlying investment portfolio.

As of March 31, 2025, SLF JV I had $374.7 million in assets, including senior secured loans to 52 portfolio companies. This compared to $344.9 million in assets, including senior secured loans to 42 portfolio companies, as of December 31, 2024. SLF JV I generated cash interest income of $3.2 million for the Company during the quarter ended March 31, 2025, down from $3.4 million in the prior quarter. In addition, SLF JV I generated dividend income of $0.7 million for the Company during the quarter ended March 31, 2025, flat from the prior quarter. As of March 31, 2025, SLF JV I had $73.0 million of undrawn capacity (subject to borrowing base and other limitations) on its $270 million senior revolving credit facility, and its debt to equity ratio was 1.3x.

Glick JV

The Company's investments in Glick JV totaled $47.3 million at fair value as of March 31, 2025, down 4.6% from $49.6 million as of December 31, 2024. The decrease was primarily driven by Glick JV’s use of leverage and unrealized depreciation in the underlying investment portfolio.

As of March 31, 2025, Glick JV had $125.1 million in assets, including senior secured loans to 41 portfolio companies. This compared to $127.9 million in assets, including senior secured loans to 39 portfolio companies, as of December 31, 2024. Glick JV generated cash interest income of $1.3 million for the Company during the quarter ended March 31, 2025, down from $1.4 million in the prior quarter. As of March 31, 2025, Glick JV had $31.0 million of undrawn capacity (subject to borrowing base and other limitations) on its $100 million senior revolving credit facility, and its debt to equity ratio was 1.3x.

Liquidity and Capital Resources

As of March 31, 2025, the Company had total principal value of debt outstanding of $1,470.0 million, including $520.0 million of outstanding borrowings under its revolving credit facilities, $350.0 million of the 2.700% Notes due 2027, $300.0 million of the 7.100% Notes due 2029 and $300.0 million of the 6.340% Notes due 2030. The funding mix was composed of 35% secured and 65% unsecured borrowings as of March 31, 2025. The Company was in compliance with all financial covenants under its credit facilities as of March 31, 2025.

As of March 31, 2025, the Company had $97.8 million of unrestricted cash and cash equivalents and over $1.0 billion of undrawn capacity on its credit facilities (subject to borrowing base and other limitations). As of March 31, 2025, unfunded investment commitments were $299.8 million, or $272.6 million excluding unfunded commitments to the Company's joint ventures. Of the $272.6 million, approximately $252.0 million could be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. The Company has analyzed cash and cash equivalents, availability under its credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believes its liquidity and capital resources are sufficient to invest in market opportunities as they arise.

As of March 31, 2025, the weighted average interest rate on debt outstanding, including the effect of the interest rate swap agreements was 6.7%, up from 6.2% as of December 31, 2024, primarily driven by the impact of the repayment of the 3.500% Notes due 2025 and the issuance of the 6.340% Notes due 2030.

The Company’s total debt to equity ratio was 1.00x and 1.11x as of each of March 31, 2025 and December 31, 2024, respectively. The Company's net debt to equity ratio was 0.93x and 1.03x as of each of March 31, 2025 and December 31, 2024, respectively.

Recent Developments

Syndicated Facility

On April 8, 2025, the Company entered into an amendment to its amended and restated senior secured credit facility (the “Syndicated Facility”), among other things, (1) generally reduce interest rate margins from 2.00% plus a SOFR adjustment (ranging between 0.11448% and 0.26161%) to 1.875% plus a SOFR adjustment of 0.10% on SOFR loans and from 1.00% to 0.875% plus a SOFR adjustment of 0.10% on alternate base rate loans, (2) remove the Consolidated Interest Coverage Ratio covenant, (3) decrease the facility size from $1.218 billion to $1.160 billion, (4) increase the “accordion” feature to allow expansion of the facility to $1.50 billion, and (5) extend the reinvestment period and final maturity date to April 8, 2029, and April 8, 2030, respectively.

Non-GAAP Financial Measures

On a supplemental basis, the Company is disclosing certain adjusted financial measures, each of which is calculated and presented on a basis of methodology other than in accordance with GAAP (“non-GAAP”). The Company's management uses these non-GAAP financial measures internally to analyze and evaluate financial results and performance and believes that these non-GAAP financial measures are useful to investors as an additional tool to evaluate ongoing results and trends for the Company and to review the Company’s performance without giving effect to non-cash income/gain/loss resulting from the OCSI Merger and the OSI2 Merger and in the case of adjusted net investment income, without giving effect to capital gains incentive fees. The presentation of the below non-GAAP measures is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.

  • “Adjusted Total Investment Income” and “Adjusted Total Investment Income Per Share” – represents total investment income excluding any amortization or accretion of interest income resulting solely from the cost basis established by ASC 805 (see below) for the assets acquired in connection with the OCSI Merger and the OSI2 Merger.
  • “Adjusted Net Investment Income” and “Adjusted Net Investment Income Per Share” – represents net investment income, excluding (i) any amortization or accretion of interest income resulting solely from the cost basis established by ASC 805 (see below) for the assets acquired in connection with the OCSI Merger and the OSI2 Merger and (ii) capital gains incentive fees (“Part II incentive fees”).
  • “Adjusted Net Realized and Unrealized Gains (Losses), Net of Taxes” and “Adjusted Net Realized and Unrealized Gains (Losses), Net of Taxes Per Share” – represents net realized and unrealized gains (losses) net of taxes excluding any net realized and unrealized gains (losses) resulting solely from the cost basis established by ASC 805 (see below) for the assets acquired in connection with the OCSI Merger and the OSI2 Merger.
  • “Adjusted Earnings (Loss)” and “Adjusted Earnings (Loss) Per Share” – represents the sum of (i) Adjusted Net Investment Income and (ii) Adjusted Net Realized and Unrealized Gains (Losses), Net of Taxes and includes the impact of Part II incentive fees1, if any.

The OCSI Merger and the OSI2 Merger (the “Mergers”) were accounted for as asset acquisitions in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues (“ASC 805”). The consideration paid to each of the stockholders of OCSI and OSI2 were allocated to the individual assets acquired and liabilities assumed based on the relative fair values of the net identifiable assets acquired other than “non-qualifying” assets, which established a new cost basis for the acquired investments under ASC 805 that, in aggregate, was different than the historical cost basis of the acquired investments prior to the OCSI Merger or the OSI2 Merger, as applicable. Additionally, immediately following the completion of the Mergers, the acquired investments were marked to their respective fair values under ASC 820, Fair Value Measurements, which resulted in unrealized appreciation/depreciation. The new cost basis established by ASC 805 on debt investments acquired will accrete/amortize over the life of each respective debt investment through interest income, with a corresponding adjustment recorded to unrealized appreciation/depreciation on such investment acquired through its ultimate disposition. The new cost basis established by ASC 805 on equity investments acquired will not accrete/amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized gain/loss with a corresponding reversal of the unrealized appreciation/depreciation on disposition of such equity investments acquired.

The Company’s management uses the non-GAAP financial measures described above internally to analyze and evaluate financial results and performance and to compare its financial results with those of other business development companies that have not adjusted the cost basis of certain investments pursuant to ASC 805. The Company’s management believes “Adjusted Total Investment Income”, “Adjusted Total Investment Income Per Share”, “Adjusted Net Investment Income” and “Adjusted Net Investment Income Per Share” are useful to investors as an additional tool to evaluate ongoing results and trends for the Company without giving effect to the income resulting from the new cost basis of the investments acquired in the Mergers because these amounts do not impact the fees payable to Oaktree Fund Advisors, LLC (the “Adviser”) under its investment advisory agreement (as amended and restated from time to time, the “A&R Advisory Agreement”), and specifically as its relates to “Adjusted Net Investment Income” and “Adjusted Net Investment Income Per Share”, without giving effect to Part II incentive fees. In addition, the Company’s management believes that “Adjusted Net Realized and Unrealized Gains (Losses), Net of Taxes”, “Adjusted Net Realized and Unrealized Gains (Losses), Net of Taxes Per Share”, “Adjusted Earnings (Loss)” and “Adjusted Earnings (Loss) Per Share” are useful to investors as they exclude the non-cash income and gain/loss resulting from the Mergers and are used by management to evaluate the economic earnings of its investment portfolio. Moreover, these metrics more closely align the Company's key financial measures with the calculation of incentive fees payable to the Adviser under with the A&R Advisory Agreement (i.e., excluding amounts resulting solely from the lower cost basis of the acquired investments established by ASC 805 that would have been to the benefit of the Adviser absent such exclusion).

The following table provides a reconciliation of total investment income (the most comparable U.S. GAAP measure) to adjusted total investment income for the periods presented:

 For the three months ended
 
 March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
($ in thousands, except per share data)Amount Per Share Amount Per Share Amount Per Share
 
GAAP total investment income$77,568  $0.90 $86,647 $1.05 $94,029 $1.18 
Interest income amortization (accretion) related to merger
accounting adjustments
 (373)    423  0.01  3,311  0.04 
Adjusted total investment income$77,195  $0.90 $87,070 $1.06 $97,340 $1.22 
 

The following table provides a reconciliation of net investment income (the most comparable U.S. GAAP measure) to adjusted net investment income for the periods presented:

 For the three months ended
 
 March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
($ in thousands, except per share data)Amount Per Share Amount Per Share Amount Per Share
 
GAAP net investment income$39,055  $0.45 $44,302 $0.54 $41,367 $0.52 
Interest income amortization (accretion) related to merger
accounting adjustments
 (373)    423  0.01  3,311  0.04 
Part II incentive fee             
Adjusted net investment income$38,682  $0.45 $44,725 $0.54 $44,678 $0.56 
 

The following table provides a reconciliation of net realized and unrealized gains (losses), net of taxes (the most comparable U.S. GAAP measure) to adjusted net realized and unrealized gains (losses), net of taxes for the periods presented:

 For the three months ended
 
 March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
($ in thousands, except per share data)Amount Per Share Amount Per Share Amount Per Share
 
GAAP net realized and unrealized gains (losses), net of taxes$(75,304) $(0.88) $(37,063) $(0.45) $(32,030) $(0.40) 
Net realized and unrealized gains (losses) related to merger
accounting adjustments
 56      (61)     (3,314)  (0.04) 
Adjusted net realized and unrealized gains (losses), net of taxes$(75,248) $(0.88) $(37,124) $(0.45) $(35,344) $(0.44) 
 

The following table provides a reconciliation of net increase (decrease) in net assets resulting from operations (the most comparable U.S. GAAP measure) to adjusted earnings (loss) for the periods presented:

 For the three months ended
 
 March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 March 31, 2024
(unaudited)

 
($ in thousands, except per share data)Amount Per Share Amount Per Share Amount Per Share
 
Net increase (decrease) in net assets resulting from operations$(36,249) $(0.42) $7,239  $0.09 $9,337  $0.12  
Interest income amortization (accretion) related to merger
accounting adjustments
 (373)     423   0.01  3,311   0.04  
Net realized and unrealized gains (losses) related to merger
accounting adjustments
 56      (61)    (3,314)  (0.04) 
Adjusted earnings (loss)$(36,566) $(0.43) $7,601  $0.09 $9,334  $0.12  
 

Conference Call Information

Oaktree Specialty Lending will host a conference call to discuss its second fiscal quarter 2025 results at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time on May 1, 2025. The conference call may be accessed by dialing (877) 507-3275 (U.S. callers) or +1 (412) 317-5238 (non-U.S. callers). All callers will need to reference “Oaktree Specialty Lending” once connected with the operator. Alternatively, a live webcast of the conference call can be accessed through the Investors section of Oaktree Specialty Lending’s website, www.oaktreespecialtylending.com. During the conference call, the Company intends to refer to an investor presentation that will be available on the Investors section of its website.

For those individuals unable to listen to the live broadcast of the conference call, a replay will be available on Oaktree Specialty Lending’s website, or by dialing (877) 344-7529 (U.S. callers) or +1 (412) 317-0088 (non-U.S. callers), access code 3296634, beginning approximately one hour after the broadcast.

About Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corporation (NASDAQ:OCSL) is a specialty finance company dedicated to providing customized one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions including first and second lien loans, unsecured and mezzanine loans, and preferred equity. The Company is regulated as a business development company under the Investment Company Act of 1940, as amended, and is externally managed by Oaktree Fund Advisors, LLC, an affiliate of Oaktree Capital Management, L.P. For additional information, please visit Oaktree Specialty Lending's website at www.oaktreespecialtylending.com.

Forward-Looking Statements

Some of the statements in this press release constitute forward-looking statements because they relate to future events, future performance or financial condition. The forward-looking statements may include statements as to: future operating results of the Company and distribution projections; business prospects of the Company and the prospects of its portfolio companies; and the impact of the investments that the Company expects to make. In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this press release involve risks and uncertainties. Certain factors could cause actual results and conditions to differ materially from those projected, including the uncertainties associated with (i) changes or potential disruptions in the Company’s operations, the economy, financial markets or political environment, including those caused by tariffs and trade disputes with other countries, inflation and an elevated interest rate environment; (ii) risks associated with possible disruption in the operations of the Company or the economy generally due to terrorism, war or other geopolitical conflict, natural disasters, pandemics or cybersecurity incidents; (iii) future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities); (iv) conditions in the Company’s operating areas, particularly with respect to business development companies or regulated investment companies; and (v) other considerations that may be disclosed from time to time in the Company’s publicly disseminated documents and filings. The Company has based the forward-looking statements included in this press release on information available to it on the date of this press release, and the Company assumes no obligation to update any such forward-looking statements. The Company undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that it may make directly to you or through reports that the Company in the future may file with the Securities and Exchange Commission, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Contacts

Investor Relations:
Oaktree Specialty Lending Corporation
Clark Koury
(213) 830-6222
ocsl-ir@oaktreecapital.com

Media Relations:
Financial Profiles, Inc.
Moira Conlon
(310) 478-2700
mediainquiries@oaktreecapital.com

Oaktree Specialty Lending Corporation
Consolidated Statements of Assets and Liabilities
(in thousands, except per share amounts)
 
 March 31, 2025
(unaudited)
 December 31, 2024
(unaudited)
 September 30, 2024
 
ASSETS            
Investments at fair value:            
Control investments (cost March 31, 2025: $375,317; cost December 31, 2024: $374,509;
cost September 30, 2024: $372,901)
$230,904  $267,782  $289,404  
Affiliate investments (cost March 31, 2025: $35,295; cost December 31, 2024: $37,358;
cost September 30, 2024: $38,175)
 32,475   35,180   35,677  
Non-control/Non-affiliate investments (cost March 31, 2025: $2,703,644; cost December 31,
2024: $2,576,053; cost September 30, 2024: $2,733,843)
 2,629,392   2,532,332   2,696,198  
Total investments at fair value (cost March 31, 2025: $3,114,256; cost December 31,
2024: $2,987,920; September 30, 2024: $3,144,919)
 2,892,771   2,835,294   3,021,279  
Cash and cash equivalents 97,838   112,913   63,966  
Restricted cash 10,370   13,159   14,577  
Interest, dividends and fees receivable 22,768   25,290   38,804  
Due from portfolio companies 317   408   12,530  
Receivables from unsettled transactions 18,526   55,661   17,548  
Due from broker 25,190   21,880   17,060  
Deferred financing costs 10,196   10,936   11,677  
Deferred offering costs 161   162   125  
Derivative assets at fair value    6,652     
Other assets 1,030   1,437   775  
Total assets$3,079,167  $3,083,792  $3,198,341  
             
LIABILITIES AND NET ASSETS            
Liabilities:            
Accounts payable, accrued expenses and other liabilities$3,451  $3,371  $3,492  
Base management fee and incentive fee payable 7,332   8,930   15,517  
Due to affiliate 1,277   1,508   4,088  
Interest payable 14,087   17,600   16,231  
Payables from unsettled transactions 110,202      15,666  
Derivative liabilities at fair value 19,219   24,759   16,843  
Deferred tax liability    14     
Credit facilities payable 520,000   660,000   710,000  
Unsecured notes payable (net of $7,573, $4,401 and $4,935 of unamortized financing costs
as of March 31, 2025, December 31, 2024 and September 30, 2024, respectively)
 928,486   917,795   928,693  
Total liabilities 1,604,054   1,633,977   1,710,530  
Commitments and contingencies             
Net assets:            
Common stock, $0.01 par value per share, 250,000 shares authorized; 88,086, 82,245 and
82,245 shares issued and outstanding as of March 31, 2025, December 31, 2024 and
September 30, 2024, respectively
 881   822   822  
Additional paid-in-capital 2,367,337   2,264,449   2,264,449  
Accumulated overdistributed earnings (893,105)  (815,456)  (777,460) 
Total net assets (equivalent to $16.75, $17.63 and $18.09 per common share as of March
31, 2025, December 31, 2024 and September 30, 2024, respectively)
 1,475,113   1,449,815   1,487,811  
Total liabilities and net assets$3,079,167  $3,083,792  $3,198,341  
 


Oaktree Specialty Lending Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
 
 Three months ended
March 31, 2025 (unaudited)
 Three months ended
December 31, 2024 (unaudited)
 Three months ended
March 31, 2024 (unaudited)
 Six months ended
March 31, 2025 (unaudited)
 Six months ended
March 31, 2024 (unaudited)
 
Interest income:                    
Control investments$4,884  $5,226  $5,949  $10,110  $11,954  
Affiliate investments 159   166   10   325   334  
Non-control/Non-affiliate investments 63,915   71,809   77,803   135,724   160,524  
Interest on cash and cash equivalents 1,565   1,221   1,494   2,786   3,858  
Total interest income 70,523   78,422   85,256   148,945   176,670  
PIK interest income:                    
Control investments    830   598   830   1,142  
Affiliate investments 27   28      55     
Non-control/Non-affiliate investments 4,504   4,870   4,218   9,374   7,523  
Total PIK interest income 4,531   5,728   4,816   10,259   8,665  
Fee income:                    
Control investments       13      26  
Affiliate investments             5  
Non-control/Non-affiliate investments 1,742   1,679   2,533   3,421   3,822  
Total fee income 1,742   1,679   2,546   3,421   3,853  
Dividend income:                    
Control investments 700   700   1,400   1,400   2,800  
Non-control/Non-affiliate investments 72   118   11   190   26  
Total dividend income 772   818   1,411   1,590   2,826  
Total investment income 77,568   86,647   94,029   164,215   192,014  
Expenses:                    
Base management fee 7,515   8,144   11,604   15,659   23,081  
Part I incentive fee 6,733   7,913   8,452   14,646   17,480  
Professional fees 1,227   1,067   1,213   2,294   2,717  
Directors fees 160   160   160   320   320  
Interest expense 28,191   30,562   31,881   58,753   64,051  
Administrator expense 388   437   326   825   692  
General and administrative expenses 937   926   526   1,863   1,117  
Total expenses 45,151   49,209   54,162   94,360   109,458  
Management fees waived (183)  (750)  (1,500)  (933)  (3,000) 
Part I incentive fees waived (6,733)  (6,377)     (13,110)    
Net expenses 38,235   42,082   52,662   80,317   106,458  
Net investment income before taxes 39,333   44,565   41,367   83,898   85,556  
(Provision) benefit for taxes on net investment
income
 (278)  (263)     (541)    
Net investment income 39,055   44,302   41,367   83,357   85,556  
Unrealized appreciation (depreciation):                    
Control investments (37,686)  (23,230)  (6,193)  (60,916)  (4,854) 
Affiliate investments (642)  320   93   (322)  (832) 
Non-control/Non-affiliate investments (28,975)  (7,198)  (21,396)  (36,173)  (39,011) 
Foreign currency forward contracts (14,720)  10,494   2,244   (4,226)  (5,580) 
Net unrealized appreciation (depreciation)  (82,023)  (19,614)  (25,252)  (101,637)  (50,277) 
Realized gains (losses):                     
Control investments 13         13   786  
Affiliate investments 333   (288)     45     
Non-control/Non-affiliate investments (1,547)  (17,056)  (5,433)  (18,603)  (18,773) 
Foreign currency forward contracts 7,906   34   (1,170)  7,940   2,931  
Net realized gains (losses) 6,705   (17,310)  (6,603)  (10,605)  (15,056) 
(Provision) benefit for taxes on realized
and unrealized gains (losses)
 14   (139)  (175)  (125)  (351) 
Net realized and unrealized gains (losses), net
of taxes
 (75,304)  (37,063)  (32,030)  (112,367)  (65,684) 
Net increase (decrease) in net assets resulting
from operations
$(36,249) $7,239  $9,337  $(29,010) $19,872  
Net investment income per common share —
basic and diluted
$0.45  $0.54  $0.52  $0.99  $1.09  
Earnings (loss) per common share —
basic and diluted
$(0.42) $0.09  $0.12  $(0.35) $0.25  
Weighted average common shares outstanding —
basic and diluted
 85,916   82,245   79,763   84,061   78,797  
 



1 Adjusted earnings (loss) includes accrued Part II incentive fees. As of and for the three months ended December 31, 2024, there was no accrued Part II incentive fee liability. Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the A&R Advisory Agreement, which differs from Part II incentive fees accrued under GAAP. For the three months ended December 31, 2024, no amounts were payable under the A&R Advisory Agreement.


FAQ

What was OCSL's net asset value (NAV) per share in Q2 2025?

OCSL's NAV per share was $16.75 as of March 31, 2025, down from $17.63 as of December 31, 2024.

How much is OCSL's quarterly dividend payment for Q2 2025?

OCSL declared a quarterly distribution of $0.40 per share plus a supplemental distribution of $0.02 per share, payable on June 30, 2025.

What was OCSL's total investment income for Q2 2025?

Total investment income was $77.6 million ($0.90 per share), down from $86.6 million ($1.05 per share) in Q1 2025.

What percentage of OCSL's debt investments are on non-accrual status?

As of March 31, 2025, 4.6% of debt investments at fair value were on non-accrual status, up from 3.9% in the previous quarter.

How much new investment commitments did OCSL originate in Q2 2025?

OCSL originated $407.0 million of new investment commitments during Q2 2025, with a weighted average yield of 9.5% on new debt investments.
Oaktree Specialty

NASDAQ:OCSL

OCSL Rankings

OCSL Latest News

OCSL Stock Data

1.21B
80.01M
2.71%
47.66%
0.79%
Asset Management
Financial Services
Link
United States
LOS ANGLES